{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-062559","form_type":"8-K","ticker":"TOVX","cik":"0000894158","company_name":"Theriva Biologics, Inc.","filed_at":"2025-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.697374+00:00","generated_at":"2026-05-18T21:47:27.091701+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Theriva Biologics sets 2025 annual meeting for August 29; proxy deadlines revised","bullets":["Annual meeting scheduled for August 29, 2025; record date for voting is July 8, 2025.","Stockholder proposals under Rule 14a-8 must be received by July 5, 2025 for inclusion in proxy materials.","Director nominations or other proposals not seeking inclusion must be delivered by July 5, 2025.","Universal proxy rule compliance notice for director nominees also due by July 5, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-062559","json":"https://secwatch.observer/filing/0001104659-25-062559.json","markdown":"https://secwatch.observer/filing/0001104659-25-062559.md","text":"https://secwatch.observer/filing/0001104659-25-062559.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/894158/000110465925062559/0001104659-25-062559-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/894158/000110465925062559/tm2518991d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T21:47:27.091701+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}